Mid-day market update: Barnes & Noble Education drops following Q2 results, Cumberland Pharmaceuticals shares jump

Midway through trading Tuesday, the Dow traded down 0.88% to 34,827.81 while the NASDAQ fell 0.78% to 15,659.31. The S&P also fell, dropping 0.3832% to 4,616.53.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 49,301,070 cases with around 801,320 deaths. India confirmed a total of at least 34,587,820 cases and 468,980 deaths, while Brazil reported over 22,084,740 COVID-19 cases with 614,420 deaths. In total, there were at least 262,549,830 cases of COVID-19 worldwide with more than 5,227,930 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer discretionary shares slipped by just 0.2% on Tuesday. Meanwhile, top gainers in the sector included Betterware de Mexico, S.A.B. de C.V. BWMX +2.72% (Get Free Alerts for BWMX), up 6% and Chegg, Inc. CHGG +3.93% (Get Free Alerts for CHGG) up 5%.

In trading on Tuesday, communication services shares tumbled 1.3%.

Top Headline

JinkoSolar Holding Co Ltd JKS -6.23% reported a decline in sales for the third quarter and issued weak sales outlook.

JinkoSolar reported a third-quarter FY21 revenue decline of 2.3% year-on-year to $1.33 billion, missing the consensus of $1.34 billion. Non-GAAP earnings per ordinary share were $0.01, and non-GAAP earnings per ADS were $0.05.

JinkoSolar sees Q4 revenue of $1.8 billion - $2.2 billion, below the consensus of $2.24 billion.

Equities Trading UP

Cumberland Pharmaceuticals Inc. CPIX +114.55% shares shot up 127% to $4.99. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration.

Shares of Vir Biotechnology, Inc. VIR +15.24% got a boost, shooting 23% to $49.95 after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $135 to $200.

ImmunoGen, Inc. IMGN +23.13% shares were also up, gaining 36% to $6.45 in reaction to positive topline data from the SORAYA trial of mirvetuximab soravtansine for ovarian cancer. The trial is evaluating mirvetuximab as monotherapy in patients with folate receptor alpha (FRα)-high platinum-resistant ovarian cancer who have been previously treated with Roche Holdings’ Avastin (bevacizumab).

Equities Trading DOWN

Olema Pharmaceuticals, Inc. OLMA -59.02% shares tumbled 56% to $9.73 after the company announced first clinical data from the Phase 1 dose-escalation portion of the ongoing Phase 1/2 clinical trial of OP-1250.

Shares of TG Therapeutics, Inc. TGTX -41.65% were down 41% to $13.75 after the company reported the FDA plans to host a meeting of the Oncologic Drugs Advisory Committee in connection with its review of the pending BLA/sNDA for the combination of ublituximab and UKONIQ.

Barnes & Noble Education, Inc. BNED -18.58% was down, falling 20% to $7.11 after the company reported worse-than-expected Q2 EPS and sales results.


In commodity news, oil traded down 2.9% to $67.94, while gold traded up 1.3% to $1,805.00.

Silver traded up 1.8% Tuesday to $23.265 while copper fell 0.1% to $4.3385.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.42%, the Spanish Ibex Index fell 1.14% and the German DAX 30 dropped 0.46%. Meanwhile, the London’s FTSE 100 fell 0.29%, French CAC 40 fell 0.46% and Italy’s FTSE MIB dipped 0.37%.

Spain's retail sales fell 0.7% year-over-year in October. The annual inflation rate in France accelerated to 2.8% in November from 2.6% in October, while quarterly economic growth was confirmed at 3% on quarter in the third quarter. Household consumption of goods in France slipped 0.4% in October, while industrial producer prices increased 2.9% in October. Italy’s gross domestic product expanded by 2.6% on the quarter during the three months to September. The number of unemployed people in Germany fell by 34,000 to 2.428 million in November, while unemployment rate stood at 3.3% in October.


The S&P CoreLogic Case-Shiller 20-city home price index climbed 19.1% year-over-year in September.

The FHFA's house price index rose 0.9% from a month ago in September.

The Chicago PMI fell to 61.8 in November from prior reading of 68.4.

The Conference Board’s consumer confidence index dropped to 109.5 in November from previous reading of 111.6.

Data on farm prices for October will be released at 3:00 p.m. ET.

Benzinga does not provide investment advice. All rights reserved.

Feed news

Latest Forex Analysis

Latest Forex Analysis

Editors’ Picks

EUR/USD struggles to rebound, holds near 1.1150 after US data

EUR/USD trades around 1.1150 in the early American session on Friday as investors assess the latest inflation data from the US. According to the US Bureau of Economic Analysis, Core PCE Price Index rose to 4.9% on a yearly basis in December from 4.7% in November, surpassing the market expectation of 4.8%. 


GBP/USD clings to small gains above 1.3400 on mixed US data

GBP/USD posts modest daily gains slightly above 1.3400 on Friday as the dollar rally loses steam. The data from the US showed that the core PCE inflation edged higher to 4.9% in December. On a negative note, Personal Spending contracted by 0.6% on a monthly basis.


Gold recovers modestly after US data, stays below $1,800

Gold managed to stage a rebound from the multi-week low it set below $1,780 but continues to trade deep in the red near $1,790. The benchmark 10-year US Treasury bond yield is rising more than 1% on the day after US data, limiting XAU/USD's recovery.

Gold News

Bitcoin Weekly Forecast: Federal Reserve cannot tame BTC’s uptrend

Bitcoin has experienced some significant losses over the past few weeks, with a more dramatic drop occurring this week after the Fed's decision was announced. As losses have extended and BTC has entered into the $30,000 zone, concerns regarding Bitcoin being in a bear market have increased.

Read more

Apple share price set to rise after another record quarter

With the Nasdaq closing at its lowest level in seven months yesterday, the Apple share price has also found itself on the end of the recent weakness in tech shares, down over 12% from its record highs in early January.

Read more